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The purpose of this study was to examine the prevalence of self-reported snoring, apnoeas and daytime sleepiness in
relation to chronic bronchitis, recurrent wheeze, physician-diagnosed asthma and rhinitis.
This was a questionnaire study in a representative sample of a general population. The study was a part of the
Obstructive Lung Disease in Northern Sweden Studies (OLIN). A total of 5424 subjects aged 20–69 years, born on
the 15th day of each month, participated in the study. Eligible answers were obtained from 4648 subjects (85?7%).
Having snoring as a problem was reported by 10?7%. Among subjects with chronic bronchitis it was reported by
25?9%, with recurrent wheeze by 21?3%, with physician-diagnosed asthma by 17?9%, and with rhinitis by 14?7%.
Relatives’ concerns of witnessed apnoea was reported by 6?8% of all subjects, while among subjects with chronic
bronchitis it was reported by 18?1%, with recurrent wheeze by 17?1%, with physician-diagnosed asthma by 14?3%,
and with rhinitis by 9?1%. After correction for age, gender and smoking habits, chronic bronchitis, rhinitis, asthma,
and current smoking were significantly related, with snoring as a problem and with relatives’ concern of witnessed
apnoeas. Symptoms of daytime sleepiness were significantly related with concern of witnessed apnoeas, chronic
bronchitis, snoring as a problem, recurrent wheeze and age 50–59 years.
In conclusion, respiratory symptoms and conditions affecting mainly the lower respiratory tract, such as chronic
bronchitis and asthma, were related with symptoms common in obstructive sleep apnoea.
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Sleep-disordered breathing (SDB) is an old reality but a
new scientific entity. During the last decades it has been
recognized and defined as partial or complete upper airway
collapse including snoring, hypopnoeas and apnoeas. It is
referred to as a progressive disorder continuing from
snoring to obstructive sleep apnoea (OSA), with daytime
sleepiness as the main symptom (1–3).
Habitual snoring is reported by 44–63% of men and by
27–36% of women in a general population (4–6). Ob-
structive sleep apnoea syndrome, defined as apnoea–
hypopnoeas index (AHI) 10 h71 together with daytimeReceived 8 November 2000 and accepted in revised form 9
February 2001.
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old and at 1?1% in women (5).
There is evidence that SDB is related to increased
morbidity from automobile accidents (7), cardiovascular
diseases and, in combinations with chronic obstructive
pulmonary disease (COPD), with pulmonary hypertension
(8–13).
Asthma and chronic bronchitis are also common
disorders and causes of morbidity and mortality. The
prevalence of asthma among adults in Northern Sweden is
around 8% (14), and of chronic bronchitis around 10%
(15). Studies have found an increased prevalence of snoring
in bronchitic subjects (16–19). There is, however, no
evidence that obstructive sleep apnoea is more common
in subjects with COPD (20,21).
The Obstructive Lung Disease in Northern Sweden
Studies (OLIN) have studied obstructive lung diseases
and allergic conditions by cross-sectional and longitudinal
population-based studies since 1985. The OLIN studies give
opportunities to investigate the prevalence and co-variation# 2001 HARCOURT PUBLISHERS LTD
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increased upper airway resistance, such as snoring and
witnessed sleep apnoeas. The aim of this study was to
examine the relation between reported snoring as a problem
and witnessed sleep apnoeas with chronic bronchitis,
asthma and rhinitis in a general population sample.
Material and methods
The study was conducted simultaneously with a follow-up
study of asthma (22). The study area was the most northern
province of Sweden, Norrbotten, and it has been described
extensively (23).
STUDY POPULATION
All 5682 subjects in the province aged 20–69 years, born on
the 15th day of each month, were invited to complete a
postal questionnaire survey. The questions included re-
spiratory symptoms and diseases, smoking habits and
profession. Of the 5682 subjects, 5424 also received
questions about symptoms related to obstructive sleep
apnoea. Two reminders were used. Eligible answers were
obtained by 4648 subjects (85?7%; Table 1). The Ethics
Committee of the University Hospital of Northern Sweden
and the University of Umea˚ approved the study.
METHODS
The questionnaire was developed from a revised version
(24) of the British Medical Research Council’s question-
naire (25) after influences from the ATS (26) and the
Tucson studies questionnaires (27), and has been frequently
used in Nordic countries (14,28). The questionnaire (23) has
previously been validated (29,30).
Four items were chosen from the questionnaire regarding
respiratory symptoms and diseases:
1. Physician-diagnosed asthma: ‘Have you been
diagnosed by a physician as having asthma?’
2. Recurrent wheeze: ‘Do you usually have wheezing,
whistling, or a noisy sound in your chest when
breathing?’
3. Chronic bronchitis: ‘Do you bring up phlegm when
coughing on most days during periods of at least 3
months during at least 2 successive years?’TABLE 1. Subjects invited and participated in the study by age
20–29 years 30–39 years 40–49 yea
M F MF M F MF M F M
Invited 588 525 1113 645 567 1212 626 534 1
Participated 478 462 940 524 509 1033 541 497 1
Percent 81.3 88.0 84.5 81.2 89?8 85?2 86?4 93?1 8
M, male; F, female.4. Rhinitis: ‘Do you have or have you ever had allergic
eye/nose catarrh (hay-fever)?’
The questionnaire also included four questions related to
obstructive sleep apnoea, previously used in a prevalence
study in a bronchitic cohort (18).
The definitions of symptoms related to OSAS were:
1. Snoring as a problem: ‘Do you snore so much that you
think it is a problem?’
2. Worry of witnessed apnoeas: ‘Have relatives expressed
worry about you stopping breathing while you are
asleep?’
3. ‘Do you feel completely rested after a full night’s sleep?’
4. ‘Do you nod off during breaks in daytime activities?’
Subjects who gave a positive answer to question 4 and/or
a negative answer to question 3 were regarded to have
daytime sleepiness.
ANALYSIS
Statistical analyses were performed by using the Statistical
Package for Social Sciences (SPSS). The chi-square test was
used for bivariate comparisons. Multiple logistic regression
analysis was used to assess the simultaneous influences of
the different independent variables, including respiratory
symptoms and diseases on the various symptoms caused by
sleep disturbances. A P-value 50?05 was considered as
statistically significant.
Results
PREVALENCE OF AIRWAY DISEASES AND
SYMPTOMS
Physician-diagnosed asthma was reported by 6?6% of men
and by 7?6% of women. The prevalence of asthma was
significantly most common in the 20–29-year-old respon-
dents and lowest in the 40–59-year-olds in both men and
women (Fig.1). The prevalence of recurrent wheeze was
12?1% in men and 11?5% in women, and increased
significantly with age among men but not among women
(Fig. 2). Chronic bronchitis increased significantly with age
and was reported by 7?6% of men and 6?7% of women
(Fig. 1). The prevalence of rhinitis was 18?5% in men andand gender
rs 50–59 years 460 years All
F M F MF M F MF M F MF
160 485 467 952 472 515 987 2816 2608 5424
038 421 426 847 385 405 790 2349 2299 4648
9?5 86?8 91?2 89?0 81?6 78?6 80?0 83?4 88?2 85?7
FIG. 1. Prevalence of chronic bronchitis (CB) and asthma in per cent in males and females, respectively.
FIG. 2. Prevalence of rhinitis and recurrent wheeze in per cent in males and females, respectively.
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both men and women (Fig. 2).
SMOKING
The proportions of current smokers were 28?8% in men,
and 32?4% in women. Of men, 24?1% were ex-smokers and
47?1% were non-smokers. In women, 15?9% were ex-
smokers and 51?6% were non-smokers (Fig. 3).
SYMPTOMS RELATED TO OBSTRUCTIVE
SLEEP APNOEA
Snoring as a problem was reported by 10?7%, relatives’
concern of witnessed apnoea during sleep by 6?8%, and
daytime sleepiness by 28?3%. Snoring as a problem andconcomitant daytime symptoms was reported by 5?4%. The
symptoms were significantly more common in men except
daytime sleepiness, which was equally prevalent in men and
women. Snoring as a problem and worry of witnessed
apnoeas were more prevalent among the subjects having
each of the respiratory symptoms and conditions used in
the analyses, and among men in both ex- and current
smokers (Table 2).
MULTI-VARIATE RELATIONSHIPS
The influence on snoring as a problem, the combination of
snoring and daytime sleepiness, and relatives’ worry of
witnessed apnoeas during sleep, respectively, by age,
gender, smoking habits, and different respiratory symptoms
and diseases were analysed by using multiple logistic
regression.
FIG. 3. Smoking habits in percentage of in males and females, respectively.
TABLE 2. The prevalence (%) of snoring as a problem, snoring as a problem with concomitant daytime sleepiness, and
relatives’ worry of witnessed apnoeas in relation to smoking habits, age, and airway conditions in males (M) and females (F)
respectively
Snoring as
a problem
Snoring and
daytime sleepiness
Relatives’ worry
of apnoeas
Variable M F All M F All M F All
Non-smokers 10?4 6?2 8?2 5?0 3?3 4?1 7?4 2?1 4?7
Ex-smokers 16?5 6?4 12?5 8?3 3?3 6?4 12?4 1?7 8?2
Current smokers 20?1 7?5 13?5 8?9 4?9 6?8 15?9 3?4 9?4
P 50?001 0?552 50?001 0?002 0?191 0?001 50?001 0?124 50?001
20–29 years 4?6 1?7 3?2 2?9 0?9 1?9 3?8 1?3 2?6
30–39 years 11?5 5?7 8?6 5?3 3?1 4?3 5?5 1?6 3?6
40–49 years 20?1 7?6 14?2 9?8 4?4 7?2 14?4 2?4 8?7
50–59 years 23?5 9?6 16?5 10?2 5?2 7?7 19?2 2?8 11?0
60–69 years 14?0 9?1 11?5 6?8 6?2 6?5 13?5 4?4 8?9
P 50?001 50?001 50?001 50?001 50?001 50?001 50?001 0?024 50?001
Chronic bronchitis Yes 31?5 18?8 25?9 18?0 13?6 16?0 26?4 8?4 18?1
Chronic bronchitis No 13?3 5?8 9?5 6?1 3?2 4?6 9?7 2?0 5?9
P 50?001 50?001 50?001 50?001 50?001 50?001 50?001 50?001 50?001
Physician-diagnosed asthma Yes 21?9 14?4 17?9 13?5 9?2 11?2 21?3 8?0 14?3
Physician-diagnosed asthma No 14?1 6?0 10?1 6?5 3?4 5?0 10?3 2?0 6?2
P 0?008 50?001 50?001 0?001 50?001 50?001 50?001 50?001 50?001
Wheezing Yes 28?1 14?0 21?3 17?5 8?7 13?3 26?3 7?2 17?1
Wheezing No 12?8 5?7 9?3 5?5 3?2 4?4 8?9 1?8 5?4
P 50?001 50?001 50?001 0?001 50?001 50?001 50?001 50?001 50?001
Rhinitis Yes 20?0 9?8 14?7 12?4 5?3 8?7 14?3 4?3 9?1
Rhinitis No 13?4 5?9 9?7 5?7 3?5 4?6 10?2 2?0 6?2
P 50?001 0?002 50?001 50?001 0?68 50?001 0?015 0?004 0?002
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diagnosed asthma, rhinitis and current smoking were
significantly related to having snoring as a problem and
also to the combination of snoring and daytime sleepiness
(Table 3). When recurrent wheeze was included in themodel, physician-diagnosed asthma became not significant.
Instead of asthma, recurrent wheeze became significantly
related with snoring and the combination of snoring as a
problem and daytime sleepiness. Age, male gender,
recurrent wheeze, chronic bronchitis, physician-diagnosed
TABLE 3. Risks (OR and 95% CI) for snoring as a problem, snoring with concomitant daytime sleepiness, relatives’ worry of
witnessed apnoeas, and daytime sleepiness, respectively, by multiple logistic regression analysis. The independent variables
were gender, age, smoking habits, and the respiratory conditions chronic bronchitis, asthma, and rhinitis. When calculating
risks for daytime sleepiness, snoring and apnoeas were also included in the model
Independent variables Dependent variables
Snoring Snoringdaytime
sleepiness
Apnoeas Daytime sleepiness
Variables Category OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Gender Women 1 1 1 1
Men 2?57 (2?09–3?17) 1?96 (1?49–2?58) 5?48 (4?05–7?43) 0?97 (0?84–1?11)
Age class 20–29 1 1 1 1
(years) 30–39 2?86 (1?85–4?40) 2?22 (1?26–3?90) 1?37 (0?80–2?33) 1?06 (0?86–1?30)
40–49 5?12 (3?38–7?75) 4?04 (2?37–6?90) 3?61 (2?24–5?82) 1?16 (0?94–1?44)
50–59 6?48 (4?25–9?86) 4?34 (2?51–7?51) 5?31 (3?28–8?60) 1?14 (0?92–1?43)
60–69 4?37 (2?82–6?77) 3?81 (2?17–6?69) 4?19 (2?55–6?90) 1?15 (0?92–1?44)
Smoking Non-smoker 1 1 1 1
habits Ex-smoker 1?13 (0?87–1?46) 1?18 (0?83–1?67) 1?17 (0?85–1?62) 1?09 (0?91–1?30)
Smoker 1?55 (1?24–1?94) 1?52 (1?12–2?06) 1?98 (1?49–2?62) 1?17 (1?01–1?37)
Respiratory
condition
Chronic
bronchitis
2?40 (1?80– 3?20) 2?74 (1?93–3?89) 2?39 (1?70–3?35) 2?02 (1?59–2?57)
Asthma 1?62 (1?16–2?27) 1?73 (1?14–2?61) 2?36 (1?60–3?48) 1?17 (0?91–1?52)
Rhinitis 1?77 (1?40–2?24) 2?02 (1?49–2?73) 1?63 (1?21–2?20) 1?21 (1?02–1?44)
OSA
symptoms
Snoring – – – 1?85 (1?47–2?32)
Apnoeas – – – 2?30 (1?73–3?04)
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associated with relatives’ concern about witnessed apnoea
during sleep.
Daytime sleepiness was significantly related to relatives’
concern about witnessed apnoea, chronic bronchitis,
snoring as a problem and recurrent wheeze, while rhinitis,
smoking, and physician-diagnosed asthma were not. How-
ever, when recurrent wheeze was excluded from the model,
rhinitis and current smoking became significant.
Discussion
Asthmatics had significantly higher prevalence of reported
snoring as a problem and worry of witnessed apnoeas than
non-asthmatics in our study, and also after adjusting for
age, sex, and smoking habits, asthma was still significantly
related with apnoeas, and snoring. Others have found
similar relation between asthma and witnessed apnoeas and
also that asthmatics have more daytime sleepiness (31,32).
However, we could not verify that daytime sleepiness is
more common in subjects with asthma. We have not found
studies supporting that asthmatics suffer from obstructive
sleep apnoea more often than respiratory healthy subjects
do. There are, however, reports that patients with nocturnalasthma and concomitant obstructive sleep apnoea have
been improved regarding their nocturnal asthma on
treatment with nasal continuing positive airway pressure
(CPAP) (33). Bronchial hyper-reactivity (BHR) was present
in four of 16 subjects with obstructive sleep apnoea in one
study, and treatment with nasal CPAP decreased their
hyper-reactivity to metacholine (34). Others have not found
any correlation between BHR and symptoms related to
upper airway obstruction (32).
As found by others, rhinitis was significantly correlated
with reported snoring as a problem and worry of witnessed
apnoeas in our study (35), and rhinitis was also significantly
related to reported daytime symptoms. Rhinitis has in some
studies also been found to be related with obstructive sleep-
apnoea, but with lack of linearity between nasal obstruction
and severity of sleep-disordered breathing (36).
Subjects with bronchitic symptoms had a higher pre-
valence of both snoring as a problem and worry of
witnessed apnoea in our study. Bronchitic symptoms
tended to correlate even stronger with snoring as a problem
when daytime symptoms, as not being rested after a full
night’s sleep or liability to ‘nod off ’ during the day, were
added to snoring. This may indicate that snoring in
bronchitic subjects inflicts more on daily life, with excessive
daytime symptoms related to deteriorated sleep. The high
428 L.-G. LARSSON ET ALprevalence of snoring as a problem in subjects with
bronchitic symptoms in our population sample is in
accordance with the high prevalence we found in a
bronchitic cohort (18,19).
There are indications that bronchitic subjects often
have signs of obstruction of the upper airways (17–19).
It is possible that the inflammation in bronchitis not
only affects the lower airways in bronchitic subjects, but
also the upper airway. It is generally considered
that snoring and sleep apnoea are not more prevalent
in subjects with chronic obstructive pulmonary disease
than in a general population (20,21). Supporting that, in
a previous study, we have found that snoring in a
bronchitic cohort was correlated with bronchitic symp-
toms and not with loss of lung function (19). It is
known that chronic obstructive pulmonary disease is highly
over-represented among subjects with bronchitic symp-
toms, and there is some evidence that bronchitic symptoms
may precede or at least occur simultaneously with the
progressive loss of lung function seen in COPD (37). This,
together with the indications that the combination of
COPD and obstructive sleep apnoea may result in a more
severe disease (7–9), makes it important to investigate
obstructive sleep apnoea when a patient with COPD, or a
patient with chronic bronchitis, presents symptoms giving
suspicion of OSA.
It is interesting that current smoking was significantly
related with both snoring and witnessed apnoeas in men
also after correction for obstructive airway conditions.
Most reports have found a relation between snoring and
smoking, and one hypothesis is that smoking acts via
chronic bronchitis. In our study both smoking and chronic
bronchitis were independently associated with snoring. It is
possible that smoking causes inflammation of the upper
airways. Another possible mechanism is decreased nicotine
concentration during night-time and less positive muscular
tone in the upper airways (38,39).
It is hardly surprising that both respiratory symptoms
and diseases, and symptoms related to obstructive sleep
apnoea, cause daytime symptoms such as not being
rested after a full night’s sleep or to have liability to
‘nodding off ’ in the daytime, since these disorders all may
disturb sleep. It is more surprising that subjects with
asthma did not express more daytime sleepiness symptoms,
though they reported more snoring and apnoeas. Further-
more, other studies have found that asthmatics have a high
degree of disrupted sleep due to night asthma
(17,31,32,35,40). We expected that these factors together
(snoring, apnoeas and night asthma) would give asthmatics
more symptoms of daytime sleepiness, and we can not
explain why our results could not confirm this. It is possible
that these asthmatics were well controlled and had less
night asthma.
In conclusion, respiratory symptoms and conditions
affecting mainly the lower respiratory tract, such as chronic
bronchitis and asthma, as well as current smoking and
history of rhinitis, were related with symptoms common in
obstructive sleep apnoea such as having snoring as a
problem and relatives being worried about witnessed
apnoeas.Acknowledgements
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